...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Structure-activity relationship study of antimalarial indolo (2,1-b)quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates.
【24h】

Structure-activity relationship study of antimalarial indolo (2,1-b)quinazoline-6,12-diones (tryptanthrins). Three dimensional pharmacophore modeling and identification of new antimalarial candidates.

机译:抗疟疾吲哚(2,1-b)喹唑啉-6,12-二酮(色胺酮)的构效关系研究。三维药效团建模和新抗疟疾候选药物的鉴定。

获取原文
获取原文并翻译 | 示例
           

摘要

A widely applicable three-dimensional QSAR pharmacophore model for antimalarial activity was developed from a set of 17 substituted antimalarial indolo[2,1-b]quinazoline-6,12-diones (tryptanthrins) that exhibited remarkable in vitro activity (below 100 ng/mL) against sensitive and multidrug-resistant Plasmodium falciparum malaria. The pharmacophore, which contains two hydrogen bond acceptors (lipid) and two hydrophobic (aromatic) features, was found to map well onto many well-known antimalarial drug classes including quinolines, chalcones, rhodamine dyes, Pfmrk cyclin dependent kinase inhibitors, malarial FabH inhibitors, and plasmepsin inhibitors. The phamacophore allowed searches for new antimalarial candidates from multiconformer 3D databases and enabled custom designed synthesis of new potent analogues.
机译:从一组17个取代的抗疟吲哚[2,1-b]喹唑啉-6,12-二酮(色胺酮)中开发了一种广泛应用的抗疟活性三维QSAR药效团模型,该化合物具有显着的体外活性(低于100 ng /毫升)对抗敏感且具有多重耐药性的恶性疟原虫疟疾。发现该药效团具有两个氢键受体(脂质)和两个疏水性(芳香族)特征,可以很好地映射到许多著名的抗疟药类别,包括喹啉,查耳酮,若丹明染料,Pfmrk细胞周期蛋白依赖性激酶抑制剂,疟疾FabH抑制剂。和纤溶酶抑制剂。吞噬载体可以从多构象3D数据库中搜索新的抗疟疾候选药物,并可以定制设计合成新的有效类似物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号